Abstract:The conventional mass spectrometry (MS)-based strategy is often inadequate for the comprehensive characterization of various size neuropeptides without the assistance of genomic information. This study evaluated sequence coverage of different size neuropeptides in two crustacean species, blue crab Callinectes sapidus and Jonah crab Cancer borealis using conventional MS methodologies and revealed limitations to mid- and large-size peptide analysis. Herein we attempt to establish a multi-scale strategy for simultaneous and confident sequence elucidation of various sizes of peptides in the crustacean nervous system. Nine novel neuropeptides spanning a wide range of molecular weights (0.9-8.2kDa) were fully sequenced from a major neuroendocrine organ, the sinus gland of the spiny lobster Panulirus interruptus. These novel neuropeptides included seven allatostatin (A- and B-type) peptides, one crustacean hyperglycemic hormone precursor-related peptide, and one crustacean hyperglycemic hormone. Highly accurate multi-scale characterization of a collection of varied size neuropeptides was achieved by integrating traditional data-dependent tandem MS, improved bottom-up sequencing, multiple fragmentation technique-enabled top-down sequencing, chemical derivatization, and in silico homology search. Collectively, the ability to characterize a neuropeptidome with vastly differing molecule sizes from a neural tissue extract could find great utility in unraveling complex signaling peptide mixtures employed by other biological systems. BIOLOGICAL SIGNIFICANCE:Mass spectrometry (MS)-based neuropeptidomics aims to completely characterize the neuropeptides in a target organism as an important first step toward a better understanding of the structure and function of these complex signaling molecules. Although liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) with data-dependent acquisition is a powerful tool in peptidomic research, it often lacks the capability for de novo sequencing of mid-size and large peptides due to inefficient fragmentation of peptides larger than 4kDa. This study describes a multi-scale strategy for complete and confident sequence elucidation of various sizes of neuropeptides in the crustacean nervous system. The aim is to fill a technical gap where the conventional strategy is inefficient for comprehensive characterization of a complex neuropeptidome without assistance of genomic information. Nine novel neuropeptides in a wide range of molecular weights (0.9-8.2kDa) were fully sequenced from a major neuroendocrine organ of the spiny lobster, P. interruptus. The resulting molecular information extracted from such multi-scale peptidomic analysis will greatly accelerate functional studies of these novel neuropeptides.

Combining Bottom-Up And Top-Down Mass Spectrometric Strategies For De Novo Sequencing Of The Crustacean Hyperglycemic Hormone From Cancer Borealis

High-definition De Novo Sequencing of Crustacean Hyperglycemic Hormone (Chh)-Family Neuropeptides

Qualitative and Quantitative Top‐down Mass Spectral Analysis of Crustacean Hyperglycemic Hormones in Response to Feeding

Expanding the Crustacean Neuropeptidome Using a Multifaceted Mass Spectrometric Approach.

Molecular cloning of crustacean hyperglycemic hormone (CHH) family members (CHH, molt-inhibiting hormone and mandibular organ-inhibiting hormone) and their expression levels in the Jonah crab, Cancer borealis

CLONINGAND EXPRESSION OF TWO GENES ENCODING TYPE I CRUSTACEAN HYPERGLYCEMIC HORMONE FAMILY FROM THE MUD CRAB SCYLLA

Isolation and Activity of a Crustacean Hyperglycemic Hormone (CHH) from Eriocheir Sinensis

Identification and characterization of a hyperglycemic hormone from freshwater giant prawn, Macrobrachium rosenbergii

Combining Microdialysis, NanoLC-MS, and MALDI-TOF/TOF to Detect Neuropeptides Secreted in the Crab, Cancer Borealis.

Measurement of neuropeptides in crustacean hemolymph via MALDI mass spectrometry

A multi-scale strategy for discovery of novel endogenous neuropeptides in the crustacean nervous system.

In Situ Identification and Mapping of Neuropeptides from the Stomatogastric Nervous System of Cancer Borealis.

Identification of Two Distinct Molt-Inhibiting Hormone-Related Peptides from the Giant Tiger Prawn Penaeus Monodon

Capillary electrophoresis coupled to MALDI mass spectrometry imaging with large volume sample stacking injection for improved coverage of C. borealis neuropeptidome

Molecular cloning of a putative crustacean hyperglycemic hormone (CHH) isoform from extra-eyestalk tissue of the blue crab (Callinectes sapidus), and determination of temporal and spatial patterns of CHH gene expression

Molecular cloning of two structure variants of crustacean hyperglycemic hormone (CHH) from the swimming crab (Portunus trituberculatus), and their gene expression during molting and ovarian development

Investigation of Signaling Molecules and Metabolites Found in Crustacean Hemolymph Via in Vivo Microdialysis Using a Multifaceted Mass Spectrometric Platform

High-confidence De Novo Peptide Sequencing Using Positive Charge Derivatization and Tandem MS Spectra Merging.

Crustacean Hyperglycaemic Hormone Gene from the Mud Crab, Scylla Paramamosain: Cloning, Distribution and Expression Profiles During the Moulting Cycle and Ovarian Development

Chh Family Peptides From An 'Eyeless' Deep-Sea Hydrothermal Vent Shrimp, Rimicaris Kairei: Characterization And Sequence Analysis

Mass Spectral Characterization of Peptide Transmitters/hormones in the Nervous System and Neuroendocrine Organs of the American Lobster Homarus Americanus